Montymo AB 200mg/10mg Tablet is a combination medication containing acebrophylline, a bronchodilator, and montelukast, a leukotriene receptor antagonist. This tablet is indicated for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and bronchitis. Acebrophylline, the bronchodilator component, relaxes airway smooth muscle, increasing airflow and improving respiratory function. Montelukast, the leukotriene receptor antagonist, blocks the action of leukotrienes, potent inflammatory mediators, thereby reducing airway constriction and hyperresponsiveness. The combination of these two agents provides comprehensive bronchodilation and anti-inflammatory effects, allowing for effective relief of bronchospasm, wheezing, and cough. Additionally, Montymo AB 200mg/10mg Tablet may also be used to treat exercise-induced bronchospasm and nocturnal asthma. The recommended dose is one tablet, taken twice daily, with or without food. Patients should be monitored for potential side effects, such as nausea, vomiting, and headache, and the medication should only be used under the guidance of a healthcare professional.